News

Opinion
WSJ Opinion: A Shakeup at the FDA
Chiefs' Rashee Rice says he has 'completely changed' after causing dangerous crash on Dallas highway Explosives found during arrest of Tennessee man who threatened public officials, police say ...
President Donald Trump downplays the influence of Laura Loomer, a right-wing provocateur, in his administration’s ...
Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...
Dr. Vinay Prasad stepped down from his role as the Food and Drug Administration’s (FDA) chief vaccine regulator following ...
Franknez.com is the #1 news site for retail investors. Millions of readers are tuning in to receive the latest economy news, ...
In a striking bipartisan move, the Senate Appropriations Committee voted 26-3 to boost the NIH’s budget by $400 million — rejecting the Trump administration’s proposed $17 billion cut and sweeping ...
Dr George Tidmarsh, a former pharmaceutical executive who joined the FDA this month, will take over Prasad’s role temporarily.
The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...
The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...
Prasad, a longtime critic of the FDA’s leniency in drug approvals, joined the agency in May. WASHINGTON — The Food and Drug ...
This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...